Thromboembolism
📧 Sign up to get email alerts when something new happens for Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: HEPARINS: INTERFERENCE IN ARGATROBAN MEASUREMENT
A clinical trial update notes interference between heparin therapy and argatroban measurement in patients with thromboembolism; the study is…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery [Phase 2]
Phase 2 trial evaluating low molecular weight heparin versus no treatment after cesarean delivery to prevent thromboembolism has completed a…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial evaluating tinzaparin as thromboprophylaxis in metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: SYMPHONY-PE Study for Treatment of Pulmonary Embolism [NA]
A clinical trials update indicates that the SYMPHONY-PE study for treating acute pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Strategies for Anticoagulation During Venovenous ECMO [NA]
Completed clinical trial evaluating anticoagulation strategies during venovenous ECMO for acute hypoxemic respiratory failure; results have …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Thromboembolism in Anorexia Nervosa
A completed clinical trial update from Odense University Hospital concerns thromboembolism in anorexia nervosa; no trial results are provide…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: AMPLATZER™ LAA Occluder Post Approval Study (PAS)
This is a post-approval study update for the AMPLATZER LAA Occluder, reporting completed results and posted findings.
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device [NA]
Clinical trial update for Lavare Cycle in patients with HeartWare LVAD; study terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating whether thromboprophylaxis impacts progression-free survival in advanced pancreatic cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Thromboprophylaxis in Oesophageal Cancer Patients [Phase 4]
Phase 4 clinical trial update on thromboprophylaxis in esophageal cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: PraxbindTM India PMS Program
A clinical trial update for PraxbindTM India PMS Program indicating completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Amplatzer™Amulet™ Post-Market Study (Amulet™PMS)
Post-market clinical study update for Amplatzer Amulet shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Registry on WATCHMAN Outcomes in Real-Life Utilization
A completed registry study evaluating WATCHMAN device outcomes in real-life use for patients with atrial fibrillation at risk of thrombus fo…
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Assessment of The Effect of Apixaban in AF
This clinical trial update notes that the apixaban study in atrial fibrillation has completed. It lists atrial fibrillation and thromboembol…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism [Phase 1]
A Phase 1 trial evaluating safety, pharmacokinetics, biodistribution, and diagnostic performance of the PET tracer [18F]GP1 for detecting th…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Tecarfarin Anti-Coagulation Trial (TACT) [Phase 3]
Phase 3 clinical trial update for Tecarfarin in anticoagulation (TACT) investigating prevention of thromboembolism and thrombosis. Status is…
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: Hip Fracture Study of GSK576428 (Fondaparinux Sodium) [Phase 3]
Phase 3 trial update for fondaparinux sodium (GSK576428) in a hip fracture study; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Comparison of Accidents and Their Circumstances With Oral Anticoagulants
This completed clinical trial evaluates accidents and the circumstances surrounding them in patients taking oral anticoagulants. It was cond…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Michelangelo - Oasis 5 [Phase 3]
Phase 3 clinical trial for thromboembolism conducted by GlaxoSmithKline has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
Clinical trial update on biomarkers related to thrombosis in patients with newly diagnosed multiple myeloma receiving chemotherapy. The stud…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome [NA]
Dose-adjusting enoxaparin thromboprophylaxis based on anti-factor Xa levels during pregnancy may improve outcomes in women at risk for fetal…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery
A completed clinical trial assessing dabigatran etexilate 150 mg once daily for prevention of thromboembolism after hip or knee replacement …
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation [Phase 3]
Phase 3 trial update evaluating warfarin (Coumadin) for preventing thromboembolism in atrial fibrillation patients undergoing catheter ablat…
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation [Phase 2]
A Phase 2 study assessing the safety of a potential new drug versus warfarin for non-valvular atrial fibrillation, completed with results po…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty [Phase 2]
Phase 2b study of DU-176b for prevention of venous thromboembolism after total hip arthroplasty has completed with results posted.